Hydroxyethyl Starch: The Effect of Molecular Weight and Degree of Substitution on Intravascular Retention In Vivo

BACKGROUND:Hydroxyethyl starch (HES) solution is characterized by its mean molecular weight (MW), concentration, and degree of substitution (DS). This character varies worldwide. METHODS:After binding fluorescein-isothiocyanate (FITC-HES), we evaluated the retention rate of three types of 6% HES in the A2 and V2 blood vessels of rat cremaster muscles using intravital microscopy in a mild hemorrhage model (10% of total blood volume). After blood withdrawal, we infused three types of FITC-HES: HES-A (MW 150–200 kDa, DS 0.6–0.68), HES-B (MW 175–225 kDa, DS 0.45–0.55), or HES-C (MW 550–850 kDa, DS 0.7–0.8) before determining the FITC-HES retention rate in the intravital microscope. RESULTS:For V2, the FITC-HES retention rates 120 min after the start of the infusion were 27% ± 7.2% of baseline values (HES-A), 65% ± 9.1% (HES-B), and 86% ± 9.6% (HES-C); for A2 they were 27% ± 6.6%, 73% ± 10.2%, and 89% ± 8.7%, respectively. HES-B and HES-C were retained in the vessels longer than HES-A (P = 0.028 for V2, P = 0.038 for A2 between HES-B and HES-A; P = 0.022 for V2, P = 0.037 for A2 between HES-C and HES-A). There was no difference in the rate of disappearance from the vessels between HES-B and HES-C. CONCLUSIONS:HES-B and HES-C are equally retained in the blood vessels. Middle-sized HES-B with low DS and middle substitution pattern stayed in the blood vessels as long as the large-sized HES. HES solutions of varying characters should be examined to optimize HES infusion.

[1]  D. Spahn,et al.  Molar substitution and C2/C6 ratio of hydroxyethyl starch: influence on blood coagulation. , 2006, British journal of anaesthesia.

[2]  S. D. De Hert,et al.  Hydroxyethyl Starch 130/0.4 Versus Modified Fluid Gelatin for Volume Expansion in Cardiac Surgery Patients: The Effects on Perioperative Bleeding and Transfusion Needs , 2005, Anesthesia and analgesia.

[3]  D. Spahn,et al.  Molecular weight of hydroxyethyl starch: is there an effect on blood coagulation and pharmacokinetics? , 2005, British journal of anaesthesia.

[4]  J. Boldt,et al.  Plasma substitutes. , 2005, Minerva anestesiologica.

[5]  P. Grände,et al.  Volume expansion of albumin, gelatin, hydroxyethyl starch, saline and erythrocytes after haemorrhage in the rat , 2005, Intensive Care Medicine.

[6]  E. Burdett,et al.  Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolaemia in volunteers , 2004, Anaesthesia.

[7]  J. Boldt Fluid choice for resuscitation of the trauma patient: a review of the physiological, pharmacological, and clinical evidence , 2004, Canadian Journal of Anesthesia/Journal canadien d'anesthésie.

[8]  C. Wardrop,et al.  Clinically practical blood volume assessment with fluorescein‐labeled HES , 2004, Transfusion.

[9]  Stephanie B. Jones,et al.  The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. , 2003, Anesthesia and analgesia.

[10]  C. Reilly,et al.  Response of the Rat Cremaster Microcirculation to Hemorrhage In Vivo: Differential Effects of Intravenous Anesthetic Agents , 2002, Shock.

[11]  P. Coriat,et al.  Voluven®, a Lower Substituted Novel Hydroxyethyl Starch (HES 130/0.4), Causes Fewer Effects on Coagulation in Major Orthopedic Surgery than HES 200/0.5 , 2001, Anesthesia and analgesia.

[12]  W. van Oeveren,et al.  A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery , 2000, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[13]  C. Wardrop,et al.  Measuring blood volume with fluorescent‐labeled hydroxyethyl starch , 2000, Critical care medicine.

[14]  K. Schimrigk,et al.  HES 200/0.5 Is not HES 200/0.5 , 1995, Thrombosis and Haemostasis.

[15]  N. Brown,et al.  The effect of cryotherapy on the cremaster muscle microcirculation in vivo. , 1994, British Journal of Cancer.

[16]  K. Messmer,et al.  Microvascular ischemia-reperfusion injury in striated muscle: significance of "reflow paradox". , 1992, The American journal of physiology.

[17]  W. Durán,et al.  Analysis of microvascular permeability to macromolecules by video-image digital processing. , 1989, Microvascular research.

[18]  R. Schaeffer,et al.  Preparation and high-performance size-exclusion chromatographic (HPSEC) analysis of fluorescein isothiocyanate-hydroxyethyl starch: macromolecular probes of the blood-lymph barrier. , 1986, Microvascular research.

[19]  G. Anderson,et al.  Quantitation of vasodilator-induced macromolecular leakage by in vivo fluorescent microscopy. , 1982, Microvascular research.

[20]  A. Yacobi,et al.  Pharmacokinetics of Hydroxyethyl Starch in Normal Subjects , 1982, Journal of clinical pharmacology.

[21]  P. Hutchins,et al.  Effects of hemorrhagic shock on the microvasculature of skeletal muscle. , 1973, Microvascular research.